Phoenix Medicaments Private Limited
About Phoenix Medicaments Private Limited
Data last updated:
Phoenix Medicaments Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 04 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2013PTC076688. Its GSTIN is 24AAHCP3541R1ZZ (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Arva Mustuffa Baldiwala and Rashida Shakirhusen Baldiwala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.2 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹42.86 Lakh (net margin 6.9%) and EBITDA of ₹64.5 Lakh (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 19% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Phoenix Medicaments Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 2 Shreeji Complex Opp. Ellisbridge Post Office Ellisbridg, E, Ahmedabad, Gujarat, India – 380006
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Phoenix Medicaments Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Phoenix Medicaments is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Phoenix Medicaments Private Limited, buy the company report.
Financials of Phoenix Medicaments Private Limited
FY 2025 filings availablePhoenix Medicaments Private Limited reported revenue of ₹6.2 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 10% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹64.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 6.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Phoenix Medicaments Private Limited, buy the company report.
Board of directors of Phoenix Medicaments Private Limited
Phoenix Medicaments has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arva Mustuffa Baldiwala | Director | 20 Jan 2017 | 9 Years 9 Months | Current |
| Rashida Shakirhusen Baldiwala | Director | 04 Sep 2013 | 13 Years 1 Months | Current |
| Mustuffa Shakirhusen Baldiwala | Director | 04 Sep 2013 | 13 Years 1 Months | Current |
Auditor
Phoenix Medicaments Private Limited is audited by Painter & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Painter & Associates | FY 2022 | 123969W |
Shareholding
The shareholding of Phoenix Medicaments Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Phoenix Medicaments Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Phoenix Medicaments Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Phoenix Medicaments Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Phoenix Medicaments has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCP3541R1ZZ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Phoenix Medicaments Private Limited, buy the company report.
Recent activity
Phoenix Medicaments Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Arva Mustuffa Baldiwala ceased to be Additional Director on 30 Sep 2017.
Frequently asked questions
Phoenix Medicaments is an active private limited company based in Ahmedabad, Gujarat, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 04 September 2013 (13+ years old) and is registered under CIN U24100GJ2013PTC076688.
Phoenix Medicaments has 3 current directors:
- Arva Mustuffa Baldiwala - Director
- Rashida Shakirhusen Baldiwala - Director
- Mustuffa Shakirhusen Baldiwala - Director
The latest financial statements of Phoenix Medicaments on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Phoenix Medicaments is 24AAHCP3541R1ZZ, registered in Gujarat.
The CIN (Corporate Identification Number) of Phoenix Medicaments is U24100GJ2013PTC076688. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Phoenix Medicaments was incorporated on 04 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Arva Mustuffa Baldiwala ceased to be Additional Director on 30 Sep 2017. Arva Mustuffa Baldiwala was appointed as Director on 20 Jan 2017. Mustuffa Shakirhusen Baldiwala was appointed as Director on 04 Sep 2013. Phoenix Medicaments has 4 board changes on record in total.
The registered office of Phoenix Medicaments is at Shop No 2 Shreeji Complex Opp. Ellisbridge Post Office Ellisbridg, E, Ahmedabad, Gujarat, India – 380006.
Phoenix Medicaments operates in the healthcare industry, in the ayurvedic products and services segment.
The compliance status of Phoenix Medicaments is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
